Animal studies showed the peptide accelerates collateral blood vessel development in ischemia
Similar content being viewed by others Introduction Pentadecapeptide BPC 157 is known to possess therapeutic efficacy on variable tissue healing and angiogenesis that is considered through the activation of nitric oxide system as reported in previous studies 1,2,3,4,5,6
Cut out the junk
doi: 10.1016/S0008-6363(01)00533-8
Many satisfied customers have shared their success stories, reinforcing the product's effectiveness in enhancing joint health, muscle recovery, and overall wellness
5 In a study examining BPC-157's effects on in vitro wound healing using human umbilical vein endothelial cells (HUVECs), treatment with BPC-157 at concentrations of 10 -9 to 10 -7 M significantly accelerated scratch-wound closure compared to vehicle-treated controls, with accompanying increases in VEGFR2 phosphorylation the primary signaling receptor through which VEGF drives endothelial proliferation and migration